Jonathan L Marks

Summary

Publications

  1. doi request reprint Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic review
    Jonathan L Marks
    Department of Rheumatology, Southampton General Hospital, Southampton University Hospitals NHS Trust, Southampton, UK SO16 6YD
    J Rheumatol Suppl 90:81-4. 2012
  2. doi request reprint Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review
    Alexandra N Colebatch
    Department of Rheumatology, Southampton General Hospital, Southampton, UK
    J Rheumatol Suppl 90:62-73. 2012
  3. ncbi request reprint Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity
    Jonathan L Marks
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton, Hampshire, UK, SO16 6YD
    Cochrane Database Syst Rev 10:CD008952. 2011
  4. ncbi request reprint Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
    Alexandra N Colebatch
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton Consultant Rheumatologist Yeovil District Hospital, Somerset, Hampshire, UK, SO16 6YD
    Cochrane Database Syst Rev 11:CD008872. 2011
  5. pmc Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity
    Jonathan L Marks
    Department of Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
    Ther Adv Musculoskelet Dis 4:149-57. 2012

Collaborators

Detail Information

Publications5

  1. doi request reprint Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic review
    Jonathan L Marks
    Department of Rheumatology, Southampton General Hospital, Southampton University Hospitals NHS Trust, Southampton, UK SO16 6YD
    J Rheumatol Suppl 90:81-4. 2012
    ..There are concerns that some current pain pharmacotherapies may increase the risk of adverse events in patients with concurrent cardiovascular (CV) or renal disease...
  2. doi request reprint Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review
    Alexandra N Colebatch
    Department of Rheumatology, Southampton General Hospital, Southampton, UK
    J Rheumatol Suppl 90:62-73. 2012
    ....
  3. ncbi request reprint Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity
    Jonathan L Marks
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton, Hampshire, UK, SO16 6YD
    Cochrane Database Syst Rev 10:CD008952. 2011
    ..There are concerns that some of the pain pharmacotherapies currently used may increase the risk of adverse events in people with rheumatoid arthritis and concurrent cardiovascular or renal disease...
  4. ncbi request reprint Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)
    Alexandra N Colebatch
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton Consultant Rheumatologist Yeovil District Hospital, Somerset, Hampshire, UK, SO16 6YD
    Cochrane Database Syst Rev 11:CD008872. 2011
    ..There have been concerns regarding the safety of using concurrent non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, or paracetamol (acetaminophen), or both, in these people...
  5. pmc Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity
    Jonathan L Marks
    Department of Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
    Ther Adv Musculoskelet Dis 4:149-57. 2012
    ..Methotrexate reduces the overall CVD burden in patients with RA. With earlier treatment of RA and earlier use of methotrexate it is possible that we may have the capability to radically change patients' long-term CVD risk...